2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percentage of patients aged 18 years and older withContinue reading “2024 MIPS Measure #19: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care”
eCQM Archive
2024 MIPS Measure #8: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2024 MIPS Measure #8: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)”
2024 MIPS Measure #7: Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2024 MIPS Measure #7: Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)”
2024 MIPS Measure #5: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2024 MIPS Measure #5: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)”
2024 MIPS Measure #1: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Intermediate Outcome – High Priority Description Percentage of patients 18-75 years of age withContinue reading “2024 MIPS Measure #1: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)”
2023 # 438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS Measure ID: #438 Collection Type: CQM, eCQM, MVP Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: EffectiveContinue reading “2023 # 438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease”
2023 # 488 Kidney Health Evaluation
CMS Measure ID: #488 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Effective Clinical CareContinue reading “2023 # 488 Kidney Health Evaluation”
2023 # 374 Closing the Referral Loop: Receipt of Specialist Report
CMS Measure ID: #374 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: No High Priority: Yes NQS Domain: Communication and CareContinue reading “2023 # 374 Closing the Referral Loop: Receipt of Specialist Report”
2023 # 370 Depression Remission at Twelve Months
CMS Measure ID: #370 Collection Type: CQM Reporting Frequency: Once per patient per year Outcome: Yes High Priority: Yes NQS Domain: Effective Clinical CareContinue reading “2023 # 370 Depression Remission at Twelve Months”
2023 # 317 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS Measure ID: #317 Collection Type: CQM Reporting Frequency: All Visits Outcome: No High Priority: No NQS Domain: Community, Population and Public Health MeasureContinue reading “2023 # 317 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented”